Intention to pursue genetic testing for breast cancer among women due for screening mammography.

Because few studies have addressed the intention to pursue testing for breast cancer susceptibility among women in the general population, we examined whether women due for routine mammography would want such testing and what factors might impact on their decision to pursue testing. A questionnaire was mailed to women > or =50 years of age who had undergone a screening mammogram 12 to 14 months before the study. Univariate and multivariable analyses were conducted to identify factors associated with intention to pursue genetic testing. Approximately 41% of respondents probably or definitely intended to pursue testing. In univariate analysis, the intention to undergo testing was not significantly associated with age, education, marital status, potential effects on health or life insurance, or physician recommendation. Although significant in univariate analysis, family history of breast cancer and ethnicity were not significant in multivariable analysis. In both univariate and multivariable analysis, factors significantly associated with intention to undergo testing included awareness of genetic testing, cancer worry, and insurance coverage of testing cost. Intention also was associated with the respondent wanting to know whether she possessed the susceptibility gene, even if that knowledge would not impact on options for early detection or treatment. Given the relatively high level of interest in testing among women at average risk of breast cancer, these results may help health care professionals educate and counsel women regarding the appropriate use of genetic testing as well as breast cancer risk factors.

[1]  Katrina Armstrong,et al.  Interest in BRCA1/2 testing in a primary care population. , 2002, Preventive medicine.

[2]  W. Burke,et al.  Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations. , 2001, American journal of medical genetics.

[3]  J. Struewing,et al.  Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. , 2000, American journal of medical genetics.

[4]  R M Groves,et al.  Consequences of reducing nonresponse in a national telephone survey. , 2000, Public opinion quarterly.

[5]  P. Devilee,et al.  Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation , 2000, The Lancet.

[6]  M P Osborne,et al.  Psychosocial aspects of cancer genetics: women at high risk for breast and ovarian cancer. , 2000, Seminars in surgical oncology.

[7]  S. Taplin,et al.  Women's knowledge and attitudes about genetic testing for breast cancer susceptibility. , 1999, Effective clinical practice : ECP.

[8]  I. Lipkus,et al.  Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  J. Allanson,et al.  Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer , 1999, Clinical genetics.

[10]  H T Lynch,et al.  Genetic testing in families with hereditary nonpolyposis colon cancer. , 1999, JAMA.

[11]  D. Bowen,et al.  Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[12]  C. Isaacs,et al.  Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. , 1997, Patient education and counseling.

[13]  M. Schwartz,et al.  The influence of psychological distress on use of genetic testing for cancer risk , 1997 .

[14]  P. Hartge,et al.  The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.

[15]  C. Richards,et al.  Screening for 185delAG in the Ashkenazim. , 1997, American journal of human genetics.

[16]  A S Whittemore,et al.  Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. , 1997, American journal of human genetics.

[17]  B. Rimer,et al.  Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population. , 1997, American journal of medical genetics.

[18]  M. Andrykowski,et al.  Interest in learning of personal genetic risk for cancer: a general population survey. , 1996, Preventive medicine.

[19]  B. Trock,et al.  BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. , 1996, JAMA.

[20]  D. Bentley,et al.  Identification of the breast cancer susceptibility gene BRCA2 , 1995, Nature.

[21]  W J Hall,et al.  Women's receptivity to testing for a genetic susceptibility to breast cancer. , 1995, American journal of public health.

[22]  C. Lerman,et al.  Interest in genetic testing among first-degree relatives of breast cancer patients. , 1995, American journal of medical genetics.

[23]  J. Struewing,et al.  Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  S. Seal,et al.  Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.

[25]  D. Easton,et al.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. , 1993, American journal of human genetics.

[26]  M. Hayden,et al.  Predictive testing for Huntington disease. , 1992, Journal of medical ethics.

[27]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[28]  B. Trock,et al.  Psychological and behavioral implications of abnormal mammograms. , 1991, Annals of internal medicine.

[29]  B. Trock,et al.  Factors associated with repeat adherence to breast cancer screening. , 1990, Preventive medicine.

[30]  D. Craufurd,et al.  UPTAKE OF PRESYMPTOMATIC PREDICTIVE TESTING FOR HUNTINGTON'S DISEASE , 1989, The Lancet.

[31]  J. Fraumeni,et al.  Risk factors for breast cancer in women in northern Alberta, Canada, as related to age at diagnosis. , 1982, Journal of the National Cancer Institute.

[32]  H. Adami,et al.  Characteristics of familial breast cancer in sweden: Absence of relation to age and unilateral versus bilateral disease , 1981, Cancer.

[33]  F. Speizer,et al.  Family history of breast cancer as a risk indicator for the disease. , 1980, American journal of epidemiology.

[34]  D. Dillman Mail and telephone surveys : the total design method , 1979 .

[35]  Pamela A Ratner,et al.  Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[36]  Ahmedin Jemal,et al.  Cancer Statistics, 2002 , 2002, CA: a cancer journal for clinicians.

[37]  D. Makuc,et al.  Urban and rural health chartbook , 2001 .

[38]  L. Caplan,et al.  Trends in mammography use and their relation to physician and other factors. , 1996, Cancer detection and prevention.

[39]  M. Morris,et al.  Reluctance to undergo predictive testing: the case of Huntington disease. , 1993, American journal of medical genetics.

[40]  A. Miller,et al.  Is routine mammography screening appropriate for women 40-49 years of age? , 1991, American journal of preventive medicine.

[41]  S. Fox,et al.  The impact of physician compliance on screening mammography for older women. , 1991, Archives of internal medicine.

[42]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.